BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 08, 2011
 |  BC Week In Review  |  Company News  |  Deals

AMAG Pharmaceuticals, MSMB Capital deal

Hematology company AMAG said it received an unsolicited offer from shareholder MSMB Capital to acquire AMAG for $18 per share, or about $380.9 million in cash, based on 21.2 million shares outstanding on May 2....

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >